Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Make Your Improvements Last: Begin With the End in Mind.

Pediatrics·2019
Same author

Maintenance of Certification: You Can Make Your Global Health Work Count.

Pediatrics·2019
Same author

First do no harm: overdiagnosis in Pediatrics.

Archivos argentinos de pediatria·2018
Same author

When technology creates uncertainty: pulse oximetry and overdiagnosis of hypoxaemia in bronchiolitis.

BMJ (Clinical research ed.)·2017
Same author

Is It Time for the USPSTF to Inform-But Not Determine-Coverage?

Annals of internal medicine·2016
Same author

The need to build capability and capacity in quality improvement and patient safety.

Pediatrics·2015
Same journal

The Role of Telemedicine on Interhospital Transfer Outcomes : A Systematic Review.

Annals of internal medicine·2026
Same journal

Prolonged Short Sleep and Its Effect on Body Weight and Composition : A Pooled Analysis of Randomized Trials.

Annals of internal medicine·2026
Same journal

In AF, LAAC was noninferior to NOAC therapy for a composite efficacy outcome and reduced non-procedure-related bleeding at 3 y.

Annals of internal medicine·2026
Same journal

How AI is affecting medical journals.

Annals of internal medicine·2026
Same journal

In adults with COPD, the BLISS score predicted risk for acute respiratory hospital admission at 2 y.

Annals of internal medicine·2026
Same journal

In AF at risk for stroke and bleeding, LAAC was not noninferior to medical therapy for a composite of thromboembolic and safety events.

Annals of internal medicine·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.

Virginia A Moyer1,

  • 1U.S. Preventive Services Task Force, Rockville, Maryland, USA.

Annals of Internal Medicine
|June 20, 2012
PubMed
Summary
This summary is machine-generated.

The U.S. Preventive Services Task Force recommends cervical cancer screening for women aged 21-65. Options include cytology every 3 years or co-testing with cytology and HPV testing every 5 years for women aged 30-65.

More Related Videos

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

Related Experiment Videos

Last Updated: May 21, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

Area of Science:

  • Preventive Medicine
  • Gynecologic Oncology
  • Public Health

Background:

  • The 2003 U.S. Preventive Services Task Force (USPSTF) guidelines for cervical cancer screening required an update.
  • New evidence on the performance of liquid-based cytology and human papillomavirus (HPV) testing necessitates a review of screening protocols.

Purpose of the Study:

  • To update the USPSTF recommendation statement on screening for cervical cancer.
  • To evaluate the comparative test performance of different screening methods and their benefits and harms.

Main Methods:

  • Systematic evidence review of new data on cytology and HPV testing.
  • Commissioned decision analysis to determine optimal screening ages, intervals, and strategies.
  • Evaluation of stand-alone HPV testing and combination testing with cytology.

Main Results:

  • Recommends screening for women aged 21–65 years using cytology every 3 years.
  • For women aged 30–65, recommends co-testing with cytology and HPV testing every 5 years for those desiring extended intervals.
  • Recommends against screening younger than 21, older than 65 (with adequate prior screening), or after hysterectomy without prior high-grade lesions.

Conclusions:

  • Cervical cancer screening recommendations updated based on current evidence.
  • Cytology every 3 years or co-testing every 5 years are recommended for women aged 21-65.
  • Specific age and risk factor criteria determine screening eligibility and frequency.